Morphic to Present at TD Cowen 43rd Annual Health Care
WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral......
Consolidated Water to Meet with Investors at the 35th
GEORGE TOWN, Cayman Islands, March 03, 2023 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and......
TG Therapeutics Announces Data Presentations from the
NEW YORK, March 03, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data......
The Shyft Group to Present at the Raymond James 44th Annual
NOVI, Mich., March 03, 2023 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North American leader in specialty......
Societal CDMO to Participate at 35th Annual Roth
SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract......
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year
WOODCLIFF LAKE, N.J., March 03, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the......
ProKidney to Participate in TD Cowen’s 43rd Annual Health
WINSTON-SALEM, N.C., March 03, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics......
China Index Holdings Sets Record Date for Dissemination of
BEIJING, March 03, 2023 (GLOBE NEWSWIRE) -- China Index Holdings Limited (NASDAQ: CIH), (“CIH” or the “Company”), a leading real estate information and......
Waldencast Announces Participation in Upcoming Consumer
NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today......
Oncternal Therapeutics to Provide Business Update and
SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the......